Description
HER2/neu (654-662) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HER2/neu (654-662) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Purity | ≥95% |
|---|---|
| Formula | C42H77N9O11 |
| Formula Wt. | 884.12 |
| Synonym | ErbB2, EGFR2, CD340 |
| Solubility | Soluble in DMSO, DMF, acetonitrile. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
NSAID; COX-1/2 and lipoxygenase inhibitor.
Purine nucleoside analog; DNA chain terminator....
Endogenous steroid hormone; ERβ, NMDA, σ1 ago...
Non-depolarizing NMJ blocker; nAChR antagonist....
Tryptamine; 5-HT1B/1D agonist, TRPV1 antagonist...
FIASMA, mAChR, 5-HT2/3/6/7, α1/2-adrenergic an...
c-MET inhibitor.
Neurotoxin frequently used to aid in modeling P...
Endogenous adhesion molecule, binds PKC, calmod...
Endogenous peptide hormone, involved in cell gr...
Benzimidazole; microtubule polymerization inhib...
DNA alkylator.
Arabinosyl transferase inhibitor.
p38 MAPK inhibitor.
Nucleoside (thymidine) analog; DNA chain termin...
PDE and adenosine deaminase inhibitor.
Quinolone alkaloid precursor of irinotecan, ori...
Furan derivative.
Pyrimidine nucleoside (cytidine) analog; DNA ch...